CYCC Annual ROA
-122.40%
-62.84%-105.51%
31 December 2023
Summary:
As of January 23, 2025, CYCC annual return on assets is -122.40%, with the most recent change of -62.84% (-105.51%) on December 31, 2023. During the last 3 years, it has fallen by -89.99% (-277.66%). CYCC annual ROA is now -284.78% below its all-time high of -31.81%, reached on December 31, 2018.CYCC ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCC Quarterly ROA
-163.64%
+4.37%+2.60%
30 September 2024
Summary:
As of January 23, 2025, CYCC quarterly return on assets is -163.64%, with the most recent change of +4.37% (+2.60%) on September 30, 2024. Over the past year, it has dropped by -35.27% (-27.48%). CYCC quarterly ROA is now -594.57% below its all-time high of -23.56%, reached on September 30, 2007.CYCC Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCC ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -105.5% | -27.5% |
| 3 y3 years | -277.7% | -123.2% |
| 5 y5 years | -284.8% | -123.2% |
CYCC ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -165.1% | at low | -295.6% | +2.6% |
| 5 y | 5-year | -277.7% | at low | -383.0% | +2.6% |
| alltime | all time | -284.8% | at low | -594.6% | +2.6% |
Cyclacel Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -163.64%(-2.6%) |
| June 2024 | - | -168.01%(+12.5%) |
| Mar 2024 | - | -149.29%(+16.3%) |
| Dec 2023 | -122.40%(+105.5%) | -128.37%(+14.4%) |
| Sept 2023 | - | -112.22%(+25.5%) |
| June 2023 | - | -89.40%(+21.9%) |
| Mar 2023 | - | -73.33%(+22.6%) |
| Dec 2022 | -59.56%(+29.0%) | -59.82%(+24.6%) |
| Sept 2022 | - | -48.02%(+8.5%) |
| June 2022 | - | -44.25%(+4.8%) |
| Mar 2022 | - | -42.24%(+2.1%) |
| Dec 2021 | -46.18%(+42.5%) | -41.36%(+4.5%) |
| Sept 2021 | - | -39.57%(+10.8%) |
| June 2021 | - | -35.71%(+5.4%) |
| Mar 2021 | - | -33.88%(-2.5%) |
| Dec 2020 | -32.41%(-27.3%) | -34.76%(-11.0%) |
| Sept 2020 | - | -39.05%(-3.3%) |
| June 2020 | - | -40.38%(-3.3%) |
| Mar 2020 | - | -41.74%(-0.7%) |
| Dec 2019 | -44.58%(+40.1%) | -42.02%(+9.8%) |
| Sept 2019 | - | -38.26%(+3.4%) |
| June 2019 | - | -36.99%(+4.2%) |
| Mar 2019 | - | -35.51%(+11.1%) |
| Dec 2018 | -31.81%(-2.8%) | -31.95%(+9.2%) |
| Sept 2018 | - | -29.25%(-0.8%) |
| June 2018 | - | -29.50%(-9.2%) |
| Mar 2018 | - | -32.49%(-7.2%) |
| Dec 2017 | -32.72%(-38.4%) | -35.01%(-14.3%) |
| Sept 2017 | - | -40.83%(-19.1%) |
| June 2017 | - | -50.49%(-2.3%) |
| Mar 2017 | - | -51.67%(-5.8%) |
| Dec 2016 | -53.08%(+0.2%) | -54.88%(+2.2%) |
| Sept 2016 | - | -53.68%(+9.2%) |
| June 2016 | - | -49.17%(+10.0%) |
| Mar 2016 | - | -44.72%(-8.1%) |
| Dec 2015 | -52.97%(-11.3%) | -48.67%(-4.8%) |
| Sept 2015 | - | -51.12%(-6.2%) |
| June 2015 | - | -54.51%(-5.9%) |
| Mar 2015 | - | -57.91%(+0.3%) |
| Dec 2014 | -59.74%(+61.5%) | -57.72%(+12.3%) |
| Sept 2014 | - | -51.40%(+2.8%) |
| June 2014 | - | -50.01%(+35.9%) |
| Mar 2014 | - | -36.79%(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -37.00%(-36.4%) | -34.33%(-19.7%) |
| Sept 2013 | - | -42.74%(+21.0%) |
| June 2013 | - | -35.33%(-44.5%) |
| Mar 2013 | - | -63.69%(+9.2%) |
| Dec 2012 | -58.15%(+9.6%) | -58.34%(+18.4%) |
| Sept 2012 | - | -49.26%(-9.8%) |
| June 2012 | - | -54.64%(+4.5%) |
| Mar 2012 | - | -52.28%(-6.5%) |
| Dec 2011 | -53.06%(-24.0%) | -55.92%(-1.0%) |
| Sept 2011 | - | -56.46%(-7.4%) |
| June 2011 | - | -60.94%(+0.8%) |
| Mar 2011 | - | -60.48%(-12.9%) |
| Dec 2010 | -69.77%(-19.0%) | -69.42%(-18.0%) |
| Sept 2010 | - | -84.68%(+3.2%) |
| June 2010 | - | -82.07%(-13.5%) |
| Mar 2010 | - | -94.85%(+4.3%) |
| Dec 2009 | -86.17%(+14.0%) | -90.94%(+5.8%) |
| Sept 2009 | - | -85.99%(-20.4%) |
| June 2009 | - | -108.06%(+21.9%) |
| Mar 2009 | - | -88.65%(+19.3%) |
| Dec 2008 | -75.58%(+118.7%) | -74.28%(+9.0%) |
| Sept 2008 | - | -68.15%(+63.9%) |
| June 2008 | - | -41.57%(+30.3%) |
| Mar 2008 | - | -31.91%(+4.9%) |
| Dec 2007 | -34.56%(-51.4%) | -30.42%(+29.1%) |
| Sept 2007 | - | -23.56%(-8.1%) |
| June 2007 | - | -25.65%(-25.3%) |
| Mar 2007 | - | -34.35%(-38.8%) |
| Dec 2006 | -71.06%(+47.0%) | -56.12%(-9.9%) |
| Sept 2006 | - | -62.31%(-3.1%) |
| June 2006 | - | -64.32%(-5.0%) |
| Mar 2006 | - | -67.71%(+46.1%) |
| Dec 2005 | -48.34%(-54.8%) | -46.34%(-10.4%) |
| Sept 2005 | - | -51.73%(-11.1%) |
| June 2005 | - | -58.20%(-2.3%) |
| Mar 2005 | - | -59.57%(-41.6%) |
| Dec 2004 | -106.85%(+15.9%) | -102.04%(-3.3%) |
| Sept 2004 | - | -105.49%(+8.1%) |
| June 2004 | - | -97.62%(-5.8%) |
| Mar 2004 | - | -103.60%(+3.8%) |
| Dec 2003 | -92.21%(+9.6%) | -99.78% |
| Dec 2002 | -84.10%(+14.7%) | - |
| Dec 2001 | -73.35%(+61.4%) | - |
| Dec 2000 | -45.44% | - |
FAQ
- What is Cyclacel Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual ROA year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly ROA year-on-year change?
What is Cyclacel Pharmaceuticals annual return on assets?
The current annual ROA of CYCC is -122.40%
What is the all time high annual ROA for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual return on assets is -31.81%
What is Cyclacel Pharmaceuticals annual ROA year-on-year change?
Over the past year, CYCC annual return on assets has changed by -62.84% (-105.51%)
What is Cyclacel Pharmaceuticals quarterly return on assets?
The current quarterly ROA of CYCC is -163.64%
What is the all time high quarterly ROA for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly return on assets is -23.56%
What is Cyclacel Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, CYCC quarterly return on assets has changed by -35.27% (-27.48%)